-
Are bacteria big or small? Scientists challenge two major rules to come up with new formulas
Time of Update: 2021-03-08
growth rate conditions, and the proposed quantitative formula also makes natural phenomena such as bacterial individual size and growth rate predictable, for example, when the bacterial growth rate and DNA replication cycle are known, the size
-
Big Leaf Fairy Mao
Time of Update: 2021-03-08
perennian herb of the Cactus Maoke. alias ) wild brown, like grass big leaf fairy mao plant height of about 40 to 70 cm
-
Ali Health: E-commerce is still picking the big beam Internet medical growth fast
Time of Update: 2021-03-08
Limited, a direct wholist subsidiary of parent company Alibaba Holding, and so far, Ali Health has operated medical devices and health care products, adult family planning, contact lenses, health food, special medical foods, and medical and health
-
Big discovery! The psychiatric drug lipeone may be a boon for stuttering patients
Time of Update: 2021-03-07
libido, previously earmarked for schizophrenia and bipolar disorder, may have some effect on stuttering, and that its function may be related to astrocytes in the brain streatum. 2019, PNAS published a study entitled Human GNPTAB Stuttering
-
"Two Big Moves" announced at the same time! Uncover Liaoning into a big capital chess game
Time of Update: 2021-03-06
On the evening of May 8th, Liaoning Chengda Co., Ltd. issued a number of announcements involving two big news: One is a long-rumoured IPO of its controlling subsidiary, Liaoning Chengda Biological Co., Ltd. ("Chengda
-
One of the "Big Three" of medical dressings, Omei Medical, is going to land on the A-shares
Time of Update: 2021-03-05
for developed countries in Europe and the United States to provide OEM licensing contract services. OEM licensing service, specifically refers to the domestic manufacturers responsible for the production of products, foreign brands
-
"One brother" easy to master, pharmacy TOP20 shuffle! 3 varieties of big rise, slow-disease medicine "over the screen", is sunny "rise"
Time of Update: 2021-03-04
varieties of attovastatin calcium tablets topped the list, chlororeta tablets for the first time on the list; first break 50 billion yuan, slow-disease drugs, the original research drug "over-screen" Figure 1:2016-2020E key city physical pharmacy
-
Nature: A big breakthrough! For the first time, a substellular group of astrological glial cells
Time of Update: 2021-03-04
Quintana said, "Finding the astrological glial cell anti-inflammatory subgroups controlled by the gut microbiome is an important advance in our understanding of inflammation of the central nervous system and its regulation.
-
What's behind the insurance company's call for big data sharing in health care?
Time of Update: 2021-03-04
, commercial health insurance for specific groups of people to provide specific products and customized services innovation ability to put forward higher requirements. supply side: the value of health insurance is insufficient China's commercial health
-
Pfizer, Merca East bid large varieties were invited to negotiate, the hospital market or another big wave!
Time of Update: 2021-03-04
of foreign enterprises this time Hunan list of proposed negotiations is not long, to negotiate six antimicrobial drug varieties, respectively, Pfizer's injection of cephalosporine sodium Shubatan sodium (1g) and fluconazole injection (100m:200mg
-
Pharmaceutical companies each make big moves to be shortlisted for the health insurance catalog
Time of Update: 2021-03-04
, the National Health Insurance Administration has published the 2019 National Health Insurance Directory Adjustment Work Programme (hereinafter referred to as the "Work Programme"). This round of medical insurance catalog adjustment, including drug transfer
-
JCI Insight: "Treasure" Ginger! Not only can take on the "big responsibility" of anti-inflammatory
Time of Update: 2021-03-03
tested the effects of 6-turmericol on the activity of phosphate phosphatase (PDE) in neophilic granulocytes and found that 6-turmericol reduced PDE activity by 40%, while significantly increasing the concentration of cAMP in cells and the activity of PKA
-
Lanzhou University "grass-shaped yuan" Guo Xusheng: small grass achievements big dream
Time of Update: 2021-03-03
Under Feng Qiang's "needle lead", Guo Xusheng took Lin Yimin, the head of Gansu Minxiang Pastoral Co., Ltd., to a grass processing enterprise in Anhui Province.
-
This little beast has a big mystery in its ears.
Time of Update: 2021-03-02
The researchers proposed a new pattern of mammalian middle ear evolution through the study of the new genus of the early Cretaceous multi-tumored beast, gai's hot river, found in Lingyuan, Liaoning Province.
-
470 million! Kyusju Tong has another big move
Time of Update: 2021-03-02
As investment in pharmaceutical research and development increases, the biopharmaceutical market is expected to reach RMB1,319.8 billion in 2030, with a compound annual growth rate of 10.9% from 2023 to 2030.
-
People's big pharmacy: to buy 1200 pharmacies
Time of Update: 2021-02-28
In order to support the company's expansion of stores, construction of logistics networks and merger and acquisition arrangements in China, The People's Big Pharmacy Chain Co., Ltd.
-
Invest another $2.5 billion! Yang Sen is going to play the next big game in China.
Time of Update: 2021-02-28
interview with mic366. Johnson and Johnson's global performance boosted confidence in this important market decision. Compared to its two other main business devices and consumer goods, the pharmaceutical business accounted for 47.4 percent
-
5 billion yuan "white medicine" market pattern changes Hengrui 19K into the big
Time of Update: 2021-02-27
, while sales of Neulasta, a long-acting dosage form, have risen rapidly since their launch, peaking at $4.715 billion in 2015, making it a well-deserved heavyweight star product. In the same year, short-acting dosage forms achieved sales of $1,049 million
-
Beda Pharmaceuticals listed two years of continuous decline in performance, trapped in the "one drug, one big" dilemma?
Time of Update: 2021-02-27
that this downward trend from 2017 to date. third-quarter results showed that Bayda Pharmaceuticals reported revenue of 928 million yuan in the first three quarters, up 20.74 percent from a year earlier, while net profit attributable
-
One heart into a retail chain pharmaceutical industry leader Chairman is optimistic about the big health
Time of Update: 2021-02-27
Yunnan listed company Yunnan Hongxiang One Heart Tang Pharmaceutical (Group) Co., Ltd. (hereinafter referred to as: One Heart Hall) recently because of three things in the listed company's pharmaceutical retail industry: First, the 2017 annual
